Dartmouth Hitchcock Medical Center/Norris Cotton Cancer Center
Lebanon, New Hampshire, 03756, United States
NCT Number: NCT00225745
The primary outcome measure for this study is plasma ghrelin level.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Lebanon, New Hampshire, 03756, United States
The primary outcome measure for this study is plasma ghrelin level, and the two primary comparison are:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
One blood draw prior to first treatment
Time frame: prior to treatment
Time frame: prior to treatment
Time frame: prior to treatment
Dartmouth-Hitchcock Medical Center
Other
Assessment of Plasma Ghrelin Levels in Patients With Pancreatic Cancer
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05675059
Digestive System Diseases, Digestive System Neoplasms
Tampa, Florida, United States
View Trial DetailsNCT03410030
Digestive System Diseases, Digestive System Neoplasms
Scottsdale, Arizona, United States
View Trial DetailsNCT04553926
Adnexal Diseases, Breast Cancer
Ansan, South Korea
View Trial DetailsNCT03096054
Breast Cancer (Triple Negative Type), Breast Diseases
Belfast, United Kingdom
View Trial Details